Sector consensus Cybin Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:00 2025-01-14 pm EST			5-day change	1st Jan Change
8.830 ^USD	-0.79%		-11.96%	+0.11%

Dec. 11	Cybin Inc. - Special Call
Nov. 18	Cybin Says Phase 2 Data Show Potential Depression Drug Offers Relief Through 1 Year	MT

Sector:

Location:

X axis:

Main competitors

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Average Target P.	Ecart obj. / dr	Nbr of analysts
CYBIN INC.	145.81	+1,072.41%	4
VERTEX PHARMACEUTICALS INCORPORATED	489.81	+18.49%	30
REGENERON PHARMACEUTICALS, INC.	1,029.20	+43.56%	24
ARGENX SE	620.84	-4.01%	16
BIONTECH SE	133.35	+19.99%	20
WUXI APPTEC CO., LTD.	64.20	+20.74%	17
BEIGENE, LTD.	280.92	+52.17%	21
NEUROCRINE BIOSCIENCES, INC.	167.67	+17.23%	24
GENMAB A/S	2,314.56	+48.08%	16
SUMMIT THERAPEUTICS INC.	26.33	+78.91%	7
INSMED INCORPORATED	88.14	+27.87%	16
SAREPTA THERAPEUTICS, INC.	184.91	+56.13%	21
VAXCYTE, INC.	149.89	+84.66%	9
EXELIXIS, INC.	34.93	-1.06%	22
WUXI BIOLOGICS (CAYMAN) INC.	18.83	+18.35%	24
ASCENDIS PHARMA A/S	186.09	+41.60%	15
PHARMAESSENTIA CORPORATION	854.80	+21.08%	5
ZEALAND PHARMA A/S	1,007.64	+44.15%	11
MADRIGAL PHARMACEUTICALS, INC.	375.00	+23.48%	15
Average	430.15	+88.62%	17
Weighted average by Cap.	537.1	+29.34%	22